PHILADELPHIA, PA—In patients with STEMI and multivessel disease, the reduction in CV death or new MI achieved in the COMPLETE ...
LONDON, England—Follow-up data from the PORTICO I study testing the self-expanding Portico transcatheter heart valve (Abbott) ...
PHILADELPHIA, PA—The first phase III study of a novel drug that inhibits the bromodomain extra-terminal (BET) protein pathway ...
LONDON, England—A new analysis of intermediate-risk patients treated with Sapien XT and Sapien 3 (Edwards Lifesciences) in ...
PHILADELPHIA, PA—Physicians shouldn’t be too hasty about dropping aspirin in all A-fib patients after PCI, as it appears ...
PHILADELPHIA, PA—Immediate angiography among comatose cardiac arrest patients who lack signs of STEMI and are successfully ...
PHILADELPHIA, PA—New inclisiran data presented here show safety and efficacy in patients with familial hypercholesterolemia ...
PHILADELPHIA, PA—Therapies using RNA interference (RNAi) to target genes that encode proteins involved in lipid and ...
A low-dose beta-blocker and aspirin regimen may buffer some of the physiologic stress of losing a loved one that puts newly ...
LONDON, England – Fewer than one in seven patients with secondary mitral regurgitation (MR) would be eligible for ...
PHILADELPHIA, PA—Preliminary data suggest that icosapent ethyl (Vascepa; Amarin) slows the progression of atherosclerosis in ...
PHILADELPHIA, PA—Prescribing statins to achieve a more aggressive LDL treatment target in patients who have had a TIA or ...